ARCHIVES

FDA To Reorganize Oncology Office Into Four Divisions By Disease Type

This article is from The Cancer Letter archive.

Vol. 36 No. 30 | August 6, 2010

Download PDF Visit The Full Archive

Related Articles

ACS Board allocated $37.5 Million to Research; More Coming

February 20, 1987

DCT Board Approves Contract Recompetitions Worth 44.8 Million In First Year Awards

November 5, 1982

FDA Expands Gleevec Indication For Children with Ph+ ALL

January 25, 2013

ODAC Recommends Taxol For Metastatic Breast Cancer

January 7, 1994

DRCCA Board Changes Center Core Grants Guidelines To Permit Payment for Control Program Directors

October 29, 1982

Budget Cut Asked By Ford Would Hold Grant Funding To 20%

January 10, 1975